Skip to main content
. 2022 Jun 22;14(13):3056. doi: 10.3390/cancers14133056

Table 1.

The miRNA-regulating activity levels in in vitro studies depending on the different enoxacin concentrations.

miRNA Conc. [µM] Effect Expression Change Cell Line Ref.
[↑/↓] Change-Fold
Cancer cells
let-7b-5p, miR-146a-5p, miR-689 50 0.5–1 4T1 (miRNA from EV), [49]
miR-100 124 0.5–1 primary ESFT spheres [37]
miR-141, miR-191 124 1.5–2 DU145, LNcap, [38]
miR-21-5p, miR-30a-3p, miR-30a-5p, miR-100-5p, miR-204-5p, miR-221-3p 124 <1.5 Cal62, STA-ET-8.2, TPC1 [39]
Let-7f, miR-26a, 124 <1.5 A673, SW1736 [37]
miR-21 100 1.5–2 MCF7 [41]
miR-16, miR-18a*, miR-21, miR-26a, miR-29b, miR-29c, miR-31, miR-193a, 124 1.5–2 HCT-116 [36]
let-7f, miR-26a, miR-99a, miR-100, miR-143, miR-145, 124 1.5–2 A673, STA-ET-8.2, TC252, primary ESFT spheres [37]
miR-21-5p, miR-30a-3p, miR-100-5p, miR-146b-5p, miR-221-3p, 124 1.5–2 Cal62, SW1736, TPC1 [39]
miR-17 *, miR29b, miR-132, miR-146a, miR-191 miR-449a, 124 1.5–2 DU145 LNcap, [38]
miR-214-3p 50 2–2.5 4T1 (cytosolic miRNA), [49]
miR-145 100 2–2.5 MCF7 [41]
miR-7, miR-16, miR-18a*, miR-29c, miR-101, miR-128, miR-181a, miR-212 124 2–2.5 HCT-116, RKO [36]
miR-100-5p, miR-146b-5p 124 2–2.5 SW1736, TPC1 [39]
miR-34a, miR-449a 124 2–2.5 DU145, LNcap [38]
let-7f, miR-99a, miR-100, miR-145 124 2–2.5 A673, STA-ET-8.2, TC252, primary ESFT spheres [37]
miR-7, miR-26a, miR-29b, miR-30a, miR-101, miR-122, miR-125a, miR-125b, miR-126, miR-128, miR-143, miR-181b, miR-205 124 2.5–3 HCT-116, RKO [36]
miR-100, miR-145 124 2.5–3 A673, TC252 [37]
miR-29b 124 2.5–3 LNcap [38]
let-7a, let-7b, miR-30a, miR-31, miR-126, miR-181b, miR-193a, miR-193b, 124 3–3.5 HCT-116, RKO [36]
let-7f, miR-143, miR-181a, 124 3–3.5 A673, STA-ET-8.2, primary ESFT spheres [37]
miR-181a, miR-193b 124 3.5–4 HCT-116 [36]
let-7b, miR-143, miR-205 124 4–4.5 HCT-116, RKO [36]
miR-143 124 4–4.5 TC252 [37]
miR-125a 124 ca. 5 HCT-116 [36]
miR-214-3p 50 ca. 22 4T1 (miRNA from EV) [49]
Non-cancer cells
miR-128-1 60 0.5–1 dnTGFβRII T cells [65]
let-7i, miR-128 50 1.5–2 HEK293 [35]
let-7b, miR-23a, miR-30e, miR-96, miR-99a, miR-125a, miR-146, miR-190, miR-199a*, 50 1.5–2 HEK293 [35]
miR-124a, miR-139, miR-152, miR-199b 50 2–2.5 HEK293 [35]
miR-29b-1, miR-145a-5p, miR-326-3p 60 2–2.5 dnTGFβRII T cells [65]
miR-181a 60 2.5–3 dnTGFβRII T cells [65]
miR-346-5 60 3–3.5 dnTGFβRII T cells [65]

Dominant negative TGF-β receptor (dnTGFβRII). Please note that “*” is not a footnote indicator, but an essential part of the name of the specific miRNA. More information regarding the miRNAs’ nomenclature can be found in miRBase [68].